Wellington Management

← Back to your selection

Activity in this selectionj-p-morgan-life-sciences-private-capital-2d7805a5

Rounds participated in: 10
Confirmed lead rounds: —
New companies: 10
Funding in participating rounds: $3.1B

By stage

Series C+6

Series A3

Series B1

By primary sector

Biotech4

AI2

Developer tools1

Ecommerce1

Fintech1

1 more

Proptech1

By country

United States9

United Kingdom1

Rounds

10 in this selection

Jul 22

Crystalys Therapeutics

Crystalys Therapeutics develops dotinurad, an oral URAT1 inhibitor for treating gout

$130MSeries B

Role not disclosed

Jun 30

Higharc

Provides AI platform for homebuilding design, estimating and construction

$95MSeries C

Role not disclosed

Jun 24

RQ Bio

Develops antibody therapies to prevent seasonal influenza in high-risk and immunocompromised patients

$115MSeries A

Role not disclosed

Jun 22

Baseten

Builds systems software for AI applications, powering inference and multi-model strategies

$1.5BSeries F

Role not disclosed

Jun 11

Current

Provides consumer fintech platform helping everyday Americans improve their financial lives

$80MSeries E

Role not disclosed

Jun 9

NinjaOne

Provides a unified IT operations platform for simplifying work

$400MSeries C

Role not disclosed